Tami Pilot-Matias,Isabelle A. Gaultier,Rakesh L. Tripathi,Christine A. Collins,Daniel E. Cohen,Barry M. Bernstein
申请号：
US13412167
公开号：
US09044480B1
申请日:
2012.03.05
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention features methods of using Compound I to suppress HCV mutants, treat treatment-experienced HCV patients, and treat HCV patients having non-CC IL28B rs12979860 genotype.
